These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22000927)

  • 1. The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans.
    De Silva A; Salem V; Long CJ; Makwana A; Newbould RD; Rabiner EA; Ghatei MA; Bloom SR; Matthews PM; Beaver JD; Dhillo WS
    Cell Metab; 2011 Nov; 14(5):700-6. PubMed ID: 22000927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
    Steinert RE; Schirra J; Meyer-Gerspach AC; Kienle P; Fischer H; Schulte F; Goeke B; Beglinger C
    Am J Clin Nutr; 2014 Aug; 100(2):514-23. PubMed ID: 24965303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial.
    Bottin JH; Swann JR; Cropp E; Chambers ES; Ford HE; Ghatei MA; Frost GS
    Br J Nutr; 2016 Jul; 116(2):360-74. PubMed ID: 27198187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eating rate during a fixed-portion meal does not affect postprandial appetite and gut peptides or energy intake during a subsequent meal.
    Karl JP; Young AJ; Montain SJ
    Physiol Behav; 2011 Mar; 102(5):524-31. PubMed ID: 21238470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
    Näslund E; Barkeling B; King N; Gutniak M; Blundell JE; Holst JJ; Rössner S; Hellström PM
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):304-11. PubMed ID: 10193877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men.
    Schmidt JB; Gregersen NT; Pedersen SD; Arentoft JL; Ritz C; Schwartz TW; Holst JJ; Astrup A; Sjödin A
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1248-56. PubMed ID: 24735885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exercise on gut peptides, energy intake and appetite.
    Martins C; Morgan LM; Bloom SR; Robertson MD
    J Endocrinol; 2007 May; 193(2):251-8. PubMed ID: 17470516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut hormone PYY(3-36) physiologically inhibits food intake.
    Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR
    Nature; 2002 Aug; 418(6898):650-4. PubMed ID: 12167864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of eating speed at breakfast on appetite hormone responses and daily food consumption.
    Shah M; Crisp K; Adams-Huet B; Dart L; Bouza B; Franklin B; Phillips M
    J Investig Med; 2015 Jan; 63(1):22-8. PubMed ID: 25361054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats.
    Reidelberger R; Haver A; Anders K; Apenteng B
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E619-29. PubMed ID: 25117406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
    Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut hormones as peripheral anti obesity targets.
    Small CJ; Bloom SR
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
    Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
    Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.
    Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A
    Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers.
    Tan T; Behary P; Tharakan G; Minnion J; Al-Najim W; Albrechtsen NJW; Holst JJ; Bloom SR
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2364-2372. PubMed ID: 28379519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-Phenylalanine on Energy Intake and Glycaemia-Impacts on Appetite Perceptions, Gastrointestinal Hormones and Gastric Emptying in Healthy Males.
    Fitzgerald PCE; Manoliu B; Herbillon B; Steinert RE; Horowitz M; Feinle-Bisset C
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32560181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.
    Field BC; Wren AM; Peters V; Baynes KC; Martin NM; Patterson M; Alsaraf S; Amber V; Wynne K; Ghatei MA; Bloom SR
    Diabetes; 2010 Jul; 59(7):1635-9. PubMed ID: 20357366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects.
    Ford HE; Peters V; Martin NM; Sleeth ML; Ghatei MA; Frost GS; Bloom SR
    Eur J Clin Nutr; 2011 Apr; 65(4):508-13. PubMed ID: 21245879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.